Comparative Study Clinical Trial
Official title:
Effect of Unani Medicine Coded Formulations for the Management of Anomalies Associated With Polycystic Ovarian Syndrome
Currently available medications for PCOS are symptom(s) oriented but have limitations because of its complex pathophysiology. The most preferred drug against PCOS is metformin which act as an insulin sensitizer to improve insulin-glucose metabolism and anovulatory cycles in PCOS. However, its use is associated with various side effects such as bloating, diarrhea and nausea. Thus, it is imperative to explore various other alternatives to combat this gynecological problem.
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in reproductive age women, with a prevalence between 5%-15%. Currently, sedentary lifestyle, excessive intake of junk food and increasing prevalence of obesity has been associated with rise in the incidence of PCOS. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06384326 -
Parental Perceptions and Acceptance of Silver Diamine Fluoride in Spain and Italy
|
||
| Recruiting |
NCT02444468 -
Preoperative Treatment of Malleolar Fractures
|
N/A | |
| Not yet recruiting |
NCT05779462 -
ENDOMETRIOSIS - MRI
|
||
| Completed |
NCT01183247 -
An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens
|
Phase 4 | |
| Completed |
NCT06229561 -
Soft Tissue Graft Versus Acellular Dermal Matrix in Preservation of Buccal Plate of Bone
|
Phase 1/Phase 2 |